Statement: Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - non metastatic breast cancer, aswell as not having Dysphagia.
Primary_evidence: Inclusion Criteria:   females, 18 or older   recurrent or progressive locally advanced, or 'triple negative' metastatic breast cancer   paraffin-embedded tissue block must be available   measurable disease   prior chemotherapy with an anthracycline, a taxane, or both (neoadjuvant, adjuvant, or metastatic setting)   0, 1 or 2 chemotherapies in the metastatic setting   adequate organ function Exclusion Criteria:   Metastatic disease confined to bone only   Symptomatic CNS metastasis   Concurrent medical condition which may increase the risk of toxicity   Unable to take oral medication